» Articles » PMID: 39434039

Synoviocyte Detachment: an Overlooked Yet Crucial Histological Aspect in Rheumatoid Arthritis

Overview
Publisher Biomed Central
Specialties Orthopedics
Physiology
Date 2024 Oct 21
PMID 39434039
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Rheumatoid arthritis (RA) is a prevalent autoimmune disorder that leads to chronic joint inflammation, deformity, disability, and systemic complications. This study aimed to analyze the clinical characteristics and synovial pathology of RA patients with synoviocyte detachment, and explore the factors associated with this phenomenon.

Methods: This was a retrospective cohort study included RA patients who underwent synovial biopsy at our center from April to September 2023. Demographic, clinical, laboratory, and synovial histological data were retrospectively collected from medical records at the time of joint synovial biopsy in patients. Microscopic examination of hematoxylin and eosin (HE)-stained synovial tissue sections categorized the samples into synoviocyte detachment and no-synoviocyte detachment groups. Clinical characteristics and synovial pathological changes were compared between the two groups, and the factors associated with synoviocyte detachment were explored through logistic regression analysis.

Results: Fifty-five RA patients were enrolled; 45 were females, and the mean age was 53.4 ± 11.8 years. Nine RA patients exhibited synoviocyte detachment. A total of 46 RA patients in the no-synoviocyte detachment group (15 with a normal lining layer and 31 with synovial cell proliferation) were included. Compared with the no-synoviocyte detachment group, the synoviocyte detachment group presented higher RF, ESR, CRP and DAS28-CRP levels (P < 0.05). The synoviocyte detachment group exhibited more prominent neovascularization (P < 0.05). ESR, DAS28-CRP and synovial neovascularization were risk factors associated with synoviocyte detachment in RA patients.

Conclusion: RA patients with synoviocyte detachment exhibit elevated clinical disease activity, marked by pronounced synovial pathology featuring increased neovascularization and less inflammatory cell infiltration. A significant reduction in lymphocyte count compared with patients with synovial cell proliferation was also observed.

Citing Articles

A 10-year knowledge mapping of T cells in rheumatoid arthritis: A bibliometric analysis.

Gao Y, Liu Y, Hao H Hum Vaccin Immunother. 2025; 21(1):2450855.

PMID: 39962980 PMC: 11845019. DOI: 10.1080/21645515.2025.2450855.


Refining synovial inflammation assessment: A modified General Synovitis Score for active rheumatoid arthritis.

Wu D, Deng Y, Huang Y, Zhao J, Long W, Peng Y Exp Ther Med. 2025; 29(3):58.

PMID: 39927277 PMC: 11803189. DOI: 10.3892/etm.2025.12808.

References
1.
Yoo S, You S, Yoon H, Kim D, Kim H, Lee K . A novel pathogenic role of the ER chaperone GRP78/BiP in rheumatoid arthritis. J Exp Med. 2012; 209(4):871-86. PMC: 3328363. DOI: 10.1084/jem.20111783. View

2.
Heidari B . Rheumatoid Arthritis: Early diagnosis and treatment outcomes. Caspian J Intern Med. 2013; 2(1):161-70. PMC: 3766928. View

3.
McInnes I, Schett G . The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011; 365(23):2205-19. DOI: 10.1056/NEJMra1004965. View

4.
Smeets T, Barg E, Kraan M, Smith M, Breedveld F, Tak P . Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis. Ann Rheum Dis. 2003; 62(7):635-8. PMC: 1754593. DOI: 10.1136/ard.62.7.635. View

5.
Nygaard G, Firestein G . Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol. 2020; 16(6):316-333. PMC: 7987137. DOI: 10.1038/s41584-020-0413-5. View